Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They could pay off the loan then set up a new loan! Dah....
I believe it's more like 81 million
Trying to sell Medical research on Amarin for $32,000.What a joke!
Your not the only one that needs help......#metoo
5,000,000 pages really. Might be a little much...how many pages were left intentionally blank 4,999,999.
This AdCom was also known as the FDA moving the goal post!
April 26 (Reuters) - The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc's cholesterol drug Praluent as a treatment to cut the risk of heart attacks, stroke and other major cardiovascular events.
The FDA's decision will allow the drug, developed along with Sanofi SA, to be prescribed to reduce the overall risk of major adverse cardiovascular events (MACE).
MACE includes heart attack, ischemic stroke, coronary heart disease and unstable chest pains requiring hospitalization.
Praluent belongs to a class of injectable biotech drugs called PCSK9 inhibitors that dramatically lower bad LDL cholesterol and reduce the risk of heart attacks and death.
Sanofi and Regeneron in February cut the list price of Praluent by 60 percent to match the price of Amgen Inc's Repatha, another treatment to cut the risk of heart attacks, as the drugmakers try to boost the sales of the drug.
The new list price for Praluent will be $5,850 a year, down from more than $14,000 a year, when it was first approved in 2015.
Sales of both Praluent and Repatha have been severely constrained by roadblocks put up by insurers looking to limit spending on the expensive drugs.
What is the street expecting? (sales)
Under the agreement, HLS will be responsible for regulatory and commercialization activities and associated costs. Amarin is responsible for providing assistance towards local filings, supplying finished product, maintaining intellectual property and continuing the development and funding of REDUCE-IT. Terms of the agreement include up-front and milestone payments to Amarin of up to US$65.0 million. These payments include a non-refundable upfront payment of US$5.0 million, as well as development, regulatory and sale-based milestones totaling up to an additional US$60.0 million. The agreement also provides for HLS to pay Amarin tiered double digit royalties on net sales of Vascepa in Canada. Amarin is obligated to supply finished product to HLS under negotiated supply terms. The agreement for supply and commercialization is for Canada only and includes all Canadian provinces.
How many times a day do you guys check
AMRN stock price?
10,20, 30 times a day!!!! Don’t lie. Me personally about 50
Late day declines are gonna bite somebody in the A** one day soon!!!!
Hell I just want to see some pic's of the illegal poaching he did in "The Bush"!!!!!
08/09/19
NDA--------Monday?
What time do the idiots post their hit piece?
Lets put some icing on the cake and file the NDA!!!
Tasty I feel the same way.Ain't nobody got time for that!!!!I got bronchitis........
75% 06/24/19 $77.00
03/18 is gonna be a big freaking deal. with nda to follow!
Could we close in the green today?
It's like listening to my parents argue! Sounds like we need some
time apart and maybe counseling. Please don't stay together for the kids.....we can't stand it anymore.
Sure would be nice to be resting at 20 verses 16,,,, while waiting for the next leg up.
2012 Really!!!!!!!!!
What about Eli Lilly
Stupid question....
Why didn't Amarin try to market Vascepa as a D.S? While running the Reduce-it study. We have a number of patents to protect Vascepa.Just asking a simple question.
sounding a little greedy to me.
Co.has a huge pipeline....I'll dip my toes in the water!
Co.has a huge pipeline....I'll dip my toes in the water!
Remember when JZ said they had more offers for the company than the 30 employees.....
If it turns red i'll throw some pocket change at it!!!!Jpm on the 9th. might be interesting.
Even if the company doesn't get bought out it would be nice to see a offer......Might put a floor in the price.
This proves Santa's not real
I think we just flushed the toilet!!!
Amarin rep hosting dinner tonight in Montgomery,AL
Guest speaker Dr. John Osborn from Texas.
Had to put some air those truck tires....16.20 weighted that mother
down.
That's the new one
Anyone seen the new commercial?
Ok that one's full.... need another truck!